Mission Creek Capital Partners, Inc. Exact Sciences Corp Transaction History

Mission Creek Capital Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $349,087 - $484,774	-4,815 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $80,584 - $110,776	893 Added 22.77%	4,815 $460,000
Q2 2021 Aug 13, 2021	BUY	$93.66 - $139.27 $212,420 - $315,864	2,268 Added 137.12%	3,922 $488,000
Q1 2021 May 14, 2021	BUY	$116.57 - $155.01 $192,806 - $256,386	1,654 New	1,654 $218,000

699

160M

5.84M

2.58M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.48B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Mission Creek Capital Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Mission Creek Capital Partners, Inc. with notifications on news.